Topic: Fosamax
Reuters US Online Report Health News | 2010-03-11 00:47:52
BOSTON (Reuters) - U.S. regulators said on Wednesday they have found no link between oral bisphosphonate osteoporosis medications such as Merck & Co Inc's Fosamax and certain thigh bone fractures. The Food and Drug Administration issued its statement following the publication of case reports of atypical subtrochanteric femur fractures -- or fractures in the bone just below the hip joint ...
Reuters US Online Report Domestic News | 2010-01-29 19:18:32
<div><p>NEW YORK (Reuters) - A Manhattan federal judge refused on Friday to dismiss a lawsuit alleging that Merck &amp; Co Inc's osteoporosis drug Fosamax caused jaw damage to an Indiana woman during the nearly eight years she took the pill.</p><p>U.S. District Judge John Keenan described ...
BusinessWeek | 2009-12-25 06:05:42
<div><h1>STRONGER BONES BUILD RESISTANCE
</h1><p>Two separate studies discussed at the symposium showed that bone-building drugs such as Merck's Fosamax, Novartis's Zometa, and Roche's Boniva may cut older women's risk of breast cancer. One paper, drawing on data from the ongoing Women's Health Initiative ...
Reuters US Online Report Health News | 2009-12-11 22:41:53
<div><p>NEW YORK (Reuters) - Women who took a commonly used class of osteoporosis drugs called bisphosphonates had significantly fewer invasive breast cancers than women not using the bone-strengthening pills, according to a new analysis of data from the Women's Health Initiative (WHI).</p><p>The analysis from a segment of ...
